Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease.
Alvarez-Guzman C, Hartleben-Matkin C, Ruiz-Lozano RE, Rodriguez-Garcia A, Quiroga-Garza ME, Valdez-Garcia JE. Alvarez-Guzman C, et al. Among authors: hartleben matkin c. J Ophthalmic Inflamm Infect. 2022 Jul 11;12(1):22. doi: 10.1186/s12348-022-00300-7. J Ophthalmic Inflamm Infect. 2022. PMID: 35816207 Free PMC article.
High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.
Alvarez-Guzman C, Valdez-Garcia JE, Ruiz-Lozano RE, Rodriguez-Garcia A, Navas-Villar CF, Hartleben-Matkin C, Pedroza-Seres M. Alvarez-Guzman C, et al. Among authors: hartleben matkin c. Int Ophthalmol. 2022 Dec;42(12):3913-3921. doi: 10.1007/s10792-022-02412-4. Epub 2022 Jul 5. Int Ophthalmol. 2022. PMID: 35789316
Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.
Khor CC, Do T, Jia H, Nakano M, George R, Abu-Amero K, Duvesh R, Chen LJ, Li Z, Nongpiur ME, Perera SA, Qiao C, Wong HT, Sakai H, Barbosa de Melo M, Lee MC, Chan AS, Azhany Y, Dao TL, Ikeda Y, Perez-Grossmann RA, Zarnowski T, Day AC, Jonas JB, Tam PO, Tran TA, Ayub H, Akhtar F, Micheal S, Chew PT, Aljasim LA, Dada T, Luu TT, Awadalla MS, Kitnarong N, Wanichwecharungruang B, Aung YY, Mohamed-Noor J, Vijayan S, Sarangapani S, Husain R, Jap A, Baskaran M, Goh D, Su DH, Wang H, Yong VK, Yip LW, Trinh TB, Makornwattana M, Nguyen TT, Leuenberger EU, Park KH, Wiyogo WA, Kumar RS, Tello C, Kurimoto Y, Thapa SS, Pathanapitoon K, Salmon JF, Sohn YH, Fea A, Ozaki M, Lai JS, Tantisevi V, Khaing CC, Mizoguchi T, Nakano S, Kim CY, Tang G, Fan S, Wu R, Meng H, Nguyen TT, Tran TD, Ueno M, Martinez JM, Ramli N, Aung YM, Reyes RD, Vernon SA, Fang SK, Xie Z, Chen XY, Foo JN, Sim KS, Wong TT, Quek DT, Venkatesh R, Kavitha S, Krishnadas SR, Soumittra N, Shantha B, Lim BA, Ogle J, de Vasconcellos JP, Costa VP, Abe RY, de Souza BB, Sng CC, Aquino MC, Kosior-Jarecka E, Fong GB, Tamanaja VC, Fujita R, Jiang Y, Waseem N, Low S, Pham HN, Al-Shahwan S, Craven ER, Khan MI, Dada R, Mohanty K, Faiq MA, Hewitt A… See abstract for full author list ➔ Khor CC, et al. Among authors: hartleben matkin c. Nat Genet. 2016 May;48(5):556-62. doi: 10.1038/ng.3540. Epub 2016 Apr 4. Nat Genet. 2016. PMID: 27064256 Free article.
[Glaucoma: trends in the study of its etiology].
Serna-Ojeda JC, Flores-Reyes EM, Hartleben-Matkin C. Serna-Ojeda JC, et al. Among authors: hartleben matkin c. Gac Med Mex. 2014 Dec;150 Suppl 3:317-23. Gac Med Mex. 2014. PMID: 25643883 Free article. Spanish.
The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
Baiza-Durán LM, Alvarez-Delgado J, Contreras-Rubio AY, Medrano-Palafox J, De Luca-Brown A, Casab-Rueda H, Cortés-Gastélum MA, Garcidueñas-Mejía MJ, Gómez-Bastar P, Gil-Carrasco F, Hartleben-Matkin C, Jiménez-Román J, Moreno-Marín ML, Paczka-Zapata JA, Velasco-Gallegos G, Vergara-Sinta M. Baiza-Durán LM, et al. Among authors: hartleben matkin c. Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):174-8. Ann Ophthalmol (Skokie). 2009. PMID: 20214051 Clinical Trial.